ERVEBO
As listed in the register: ERVEBO
72000000 pfu · solution
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Rvsv [delta] G-Zebov-Gp, Live Attenuated
- Made by
- Merck Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Merck Canada Inc |
|---|---|
| Active substance | Rvsv [delta] G-Zebov-Gp, Live Attenuated |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 72000000 pfu |
| Form | solution |
| Classification | J07BX02 · Antibiotics, antivirals and antifungals taken into the body |
| Route | intramuscular |
| Dispensing (as stated by the register) | SCHEDULE D |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02532603 |
| DPD drug code | 102162 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.